CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-06 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +90,691 | 90,691 | ||
| 2026-03-06 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +26,382 | 26,382 | ||
| 2026-03-06 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Grant or award · Stock Option (Right to Buy) | +101,574 | 101,574 | ||
| 2026-03-06 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Grant or award · Restricted Stock Units | +29,548 | 29,548 | ||
| 2026-03-06 | Owen Adams Catherine Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +263,005 | 263,005 | ||
| 2026-03-06 | Owen Adams Catherine Chief Executive Officer | Grant or award · Restricted Stock Units | +76,509 | 76,509 | ||
| 2026-03-06 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Grant or award · Stock Option (Right to Buy) | +21,766 | 21,766 | ||
| 2026-03-06 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Grant or award · Restricted Stock Units | +6,332 | 6,332 | ||
| 2026-03-06 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Grant or award · Stock Option (Right to Buy) | +90,691 | 90,691 | ||
| 2026-03-06 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Grant or award · Restricted Stock Units | +26,382 | 26,382 | ||
| 2026-03-03 | Poole Jonathan Director | Grant or award · Director Stock Options (Right to Buy) | +7,482 | 7,482 | ||
| 2026-03-03 | Poole Jonathan Director | Grant or award · Director Stock Options (Right to Buy) | +3,565 | 3,565 | ||
| 2026-03-03 | Poole Jonathan Director | Grant or award · Restricted Stock Units | +4,218 | 4,218 | ||
| 2026-03-03 | Poole Jonathan Director | Grant or award · Restricted Stock Units | +2,010 | 2,010 | ||
| 2026-02-09 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Sale | −6,950 | $23.38 | $162K | 7,609 |
| 2026-02-06 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Option exercise | +12,944 | 14,559 | ||
| 2026-02-06 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Option exercise · Restricted Stock Units | −12,944 | 12,945 | ||
| 2025-11-18 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −10,262 | $23.69 | $243K | 53,338 |
| 2025-11-18 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sale | −4,084 | $23.69 | $97K | 25,058 |
| 2025-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +9,913 | 53,687 |
Page 5 of 49 · 979 trades